Artículo
Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension
Martín Giménez, Virna Margarita
; Mocayar Maron, Feres Jose; García, Sebastián; Mazzei, Luciana Jorgelina
; Guevara, Manuel Alejandro; Yunes, Roberto Miguel Federico
; Manucha, Walter Ariel Fernando
Fecha de publicación:
03/2021
Editorial:
Medical Univ Bialystok
Revista:
Advances In Medical Sciences
ISSN:
1896-1126
e-ISSN:
1898-4002
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Hypertensive lesions induce alterations at hemodynamic, peripheral, and central levels. Anandamide (N-arachidonoylethanolamine; AEA) protects neurons from inflammatory damage, but its free administration may cause central adverse effects. AEA controlled release by nanoformulations could reduce/eliminate its side effects. The present study aimed to evaluate the effects of nanoformulated AEA (nf-AEA) on systolic blood pressure (SBP), behavior, and central/peripheral inflammatory, oxidative, and apoptotic state in spontaneously hypertensive rats (SHR). Materials/methods: Male rats were used, both Wistar Kyoto (WKY) and SHR (n = 10 per group), with/without treatment with nf-AEA (obtained by electrospraying) at a weekly dose of 5 mg/kg IP for 4 weeks. SBP was measured and behavioral tests were performed. Inflammatory/oxidative markers were quantified at the central (brain cortex) and peripheral (serum) level. Results: SHR showed hyperactivity, low anxiety, and high concentrations of central/peripheral inflammatory/oxidative markers, also higher apoptosis of brain cortical cells compared to WKY. As opposed to this group, treatment with nf-AEA in SHR significantly reduced SBP, peripheral/central inflammatory/oxidative makers, and central apoptosis. Nf-AEA also increased neuroprotective mechanisms mediated by intracellular heat shock protein 70 (Hsp70), which were attenuated in untreated SHR. Additionally, nf-AEA reversed the abnormal behaviors observed in SHR without producing central adverse effects. Conclusions: Our results suggest protective properties of nf-AEA, both peripherally and centrally, through a signaling pathway that would involve the type I angiotensin II receptor, Wilms tumor transcription factor 1, Hsp70, and iNOS. Considering non-nf-AEA limitations, this nanoformulation could contribute to the development of new antihypertensive and behavioral disorder treatments associated with neuroinflammation.
Palabras clave:
ANANDAMIDE
,
HYPERTENSION
,
INFLAMMATION
,
NANOFORMULATION
,
OXIDATIVE STRESS
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(CCT - SAN JUAN)
Articulos de CENTRO CIENTIFICO TECNOLOGICO CONICET - SAN JUAN
Articulos de CENTRO CIENTIFICO TECNOLOGICO CONICET - SAN JUAN
Articulos(IMBECU)
Articulos de INST. DE MEDICINA Y BIO. EXP. DE CUYO
Articulos de INST. DE MEDICINA Y BIO. EXP. DE CUYO
Articulos(INBIOMED)
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS
Articulos de INSTITUTO DE INVESTIGACIONES BIOMEDICAS
Citación
Martín Giménez, Virna Margarita; Mocayar Maron, Feres Jose; García, Sebastián; Mazzei, Luciana Jorgelina; Guevara, Manuel Alejandro; et al.; Central nervous system, peripheral and hemodynamic effects of nanoformulated anandamide in hypertension; Medical Univ Bialystok; Advances In Medical Sciences; 66; 1; 3-2021; 72-80
Compartir
Altmétricas